Cargando…
A systematic review of biomarkers among hospitalized patients with COVID‐19 predictive of venous thromboembolism: A communication from the Predictive and Diagnostic Variables Scientific and Standardization Committee of the ISTH
BACKGROUND: Thrombosis is reported to occur more often among patients with COVID‐19 than otherwise expected in the setting of viral pneumonia and sepsis. Systemic inflammatory biomarkers may be associated with venous thromboembolism (VTE) risk. The ISTH subcommittee on Predictive and Diagnostic Vari...
Autores principales: | Woller, Scott C., de Wit, Kerstin, Robert‐Ebadi, Helia, Masias, Camila, Klok, Frederikus A., den Exter, Paul L., Morange, Pierre‐Emmanuel, Castelli, David, Hansen, John‐Bjarne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9412137/ https://www.ncbi.nlm.nih.gov/pubmed/36032214 http://dx.doi.org/10.1002/rth2.12786 |
Ejemplares similares
-
Management of bleeding risk in patients who receive anticoagulant therapy for venous thromboembolism: Communication from the ISTH SSC Subcommittee on Predictive and Diagnostic Variables in Thrombotic Disease
por: den Exter, Paul L., et al.
Publicado: (2022) -
“ISTH guidelines for antithrombotic treatment in COVID‐19”: Comment from Huisman et al.
por: Huisman, Menno V., et al.
Publicado: (2022) -
Preventing Venous Thromboembolism in Ambulatory Patients with Cancer: A Narrative Review
por: Rossel, Anne, et al.
Publicado: (2020) -
Higher Adherence to Treatment With Low-Molecular-Weight-Heparin Nadroparin Than Enoxaparin Because of Side Effects in Cancer-Associated Venous Thromboembolism
por: van der Wall, Sake J., et al.
Publicado: (2018) -
ISTH Abstract
Publicado: (2022)